Brokerage Overview of: Freeport-McMoRan Inc. (FCX)

glaxosmithkline research

Freeport-McMoRan Inc. (FCX) belonging to the Basic Materials sector has declined -0.61% and closed its last trading session at $14.55.

The company reported its EPS on 9/29/2017. Currently, the stock has a 1 Year Price Target of $16.17.

The consensus recommendation, according to Zacks Investment research, is 2.89. The scale runs from 1 to 5 with 1 recommending Strong Buy and 5 recommending a Strong Sell.

The Stock had a 2.62 Consensus Analyst Recommendation 30 Days Ago, whereas 60 days ago and 90 days ago the analyst recommendations were 2.74 and 2.72 respectively.

Freeport-McMoRan Inc. on 9/29/2017 reported its EPS as $0.25 with the analysts projecting the EPS of the stock as $0.34. The company beat the analyst EPS Estimate with the difference of $-0.09. This shows a surprise factor of -0.265%.

Many analysts have provided their estimated foresights on Freeport-McMoRan Inc. Earnings, with 18 analysts believing the company would generate an Average Estimate of $0.43.

Whereas they predicted High and Low Earnings Estimate as $0.53 and $0.31 respectively. While in the same Quarter Previous year, the Actual EPS was $0.25.

Analysts are also projecting an Average Revenue Estimate for Freeport-McMoRan Inc. as $4.63 Million in the Current Quarter. This estimate is provided by 8 analysts.

The High Revenue estimate is predicted as 5.03 Million, while the Low Revenue Estimate prediction stands at 4.04 Million. The company’s last year sales total was 4.38 Million.

For the Current Quarter, the growth estimate for Freeport-McMoRan Inc. is 72%, while for the Next Quarter the stock growth estimate is 186.7%.

In the past 5 years, the stock showed growth of -29.54% per annum. While for the next 5 years, the growth estimate is 72.21%.

Insider Trades for Freeport-McMoRan Inc. show that the latest trade was made on 30 Sep 2017 where Ford (Gerald J), the Director completed a transaction type “Buy” in which 2715 shares were traded at a price of $14.04.

Freeport-McMoRan Inc. (FCX) has the market capitalization of $21.18 Billion. The company rocked its 52-Week High of $17.06 and touched its 52-Week Low of $11.05.

The stock has Return on Assets (ROA) of 0.7 percent. Return on Equity (ROE) stands at 4.2% and Return on Investment (ROI) of -14.2 percent.

The stock is currently showing YTD performance of 10.31 Percent. The company has Beta Value of 2.56 and ATR value of 0.44. The Weekly and Monthly Volatility stands at 2.36% and 2.49%.